HSBC covered Gerresheimer (ETR:GXI), bumping up its stock price target to 72.00EUR today
- Updated: October 16, 2016
Having a price of 71.20EUR, Gerresheimer (ETR:GXI) traded 0.00% even on the day. With the last close up 0.00% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. GXI has recorded a 50-day average of 0.00EUR and a two hundred day average of 0.00EUR. Trade Volume held steady, with 0 shares of GXI changing hands on par with the typical 0
Gerresheimer (ETR:GXI) had its stock price target upped to 72.00EUR by HSBC in an issued report released 10/12/2016. The new target price suggests a potential upside of 0.01% based on the company's previous close.
On 10/11/2016, HSBC released a statement on Gerresheimer (ETR:GXI) upped the target price from 0.00EUR to 72.00EUR that suggested an upside of 0.01%.
Recent Performance Chart
Gerresheimer has 52 week low of 0.00EUR and a one year high of 0.00EUR and has a market capitalization of 0 EUR.
General Company Details For Gerresheimer (ETR:GXI)
Gerresheimer AG is a Germany-based company that operates in the pharmaceuticals and health care industry. It is structured in three business segments: Plastic and Devices, Primary Packaging Glass and Life Science Research. The Company produces pharmaceutical packaging products, as well as drug-delivery systems made out of glass and plastics or a combination of both. Its product portfolio includes insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.